Skip to Content

Cancers, Volume 14, Issue 18

2022 September-2 - 201 articles

Cover Story: Ovarian cancer is treated with cytoreductive surgery to remove all visible cancer, in addition to platinum chemotherapy. Ultra-radical surgery, i.e., surgery involving upper abdominal organs, e.g., splenectomy, diaphragm resection, and bowel surgery, achieves this goal even when cancer has spread widely across the abdominal cavity. We analyzed cancer registry data to identify whether cancer centres practicing ultra-radical surgery have better survival than those who practice less radical surgery, including every patient with advanced ovarian cancer in the catchment of 11 UK cancer centres. We found that centres practicing ultra-radical surgery have better median survival than those who do not, even after adjusting for age and deprivation. The strength of the study is the population-based nature of the data. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (201)

  • Review
  • Open Access
30 Citations
6,898 Views
25 Pages

Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs

  • Manuel Gámez-Chiachio,
  • David Sarrió and
  • Gema Moreno-Bueno

19 September 2022

The prognosis and quality of life of HER2 breast cancer patients have significantly improved due to the crucial clinical benefit of various anti-HER2 targeted therapies. However, HER2 tumors can possess or develop several resistance mechanisms to the...

  • Article
  • Open Access
1 Citations
3,424 Views
18 Pages

Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome

  • Felix Ruoff,
  • Nicolas Kersten,
  • Nicole Anderle,
  • Sandra Jerbi,
  • Aaron Stahl,
  • André Koch,
  • Annette Staebler,
  • Andreas Hartkopf,
  • Sara Y. Brucker and
  • Markus F. Templin
  • + 3 authors

19 September 2022

In cancer, the complex interplay between tumor cells and the tumor microenvironment results in the modulation of signaling processes. By assessing the expression of a multitude of proteins and protein variants in cancer tissue, wide-ranging informati...

  • Article
  • Open Access
6 Citations
5,534 Views
18 Pages

Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants

  • Alberto Valenzuela-Palomo,
  • Lara Sanoguera-Miralles,
  • Elena Bueno-Martínez,
  • Ada Esteban-Sánchez,
  • Inés Llinares-Burguet,
  • Alicia García-Álvarez,
  • Pedro Pérez-Segura,
  • Susana Gómez-Barrero,
  • Miguel de la Hoya and
  • Eladio A. Velasco-Sampedro

19 September 2022

PALB2 loss-of-function variants are associated with significant increased risk of breast cancer as well as other types of tumors. Likewise, splicing disruptions are a common mechanism of disease susceptibility. Indeed, we previously showed, by minige...

  • Article
  • Open Access
8 Citations
6,461 Views
20 Pages

RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines

  • Matea Kurtović,
  • Nikolina Piteša,
  • Nenad Bartoniček,
  • Petar Ozretić,
  • Vesna Musani,
  • Josipa Čonkaš,
  • Tina Petrić,
  • Cecile King and
  • Maja Sabol

19 September 2022

Background: Despite significant progress in therapy, melanoma still has a rising incidence worldwide, and novel treatment strategies are needed. Recently, researchers have recognized the involvement of the Hedgehog-GLI (HH-GLI) signaling pathway in m...

  • Review
  • Open Access
74 Citations
25,204 Views
31 Pages

A Review on Annona muricata and Its Anticancer Activity

  • Suganya Ilango,
  • Dipak Kumar Sahoo,
  • Biswaranjan Paital,
  • Kavibharathi Kathirvel,
  • Jerrina Issac Gabriel,
  • Kalyani Subramaniam,
  • Priyanka Jayachandran,
  • Rajendra Kumar Dash,
  • Akshaya Kumar Hati and
  • Ramalingam Nirmaladevi
  • + 2 authors

19 September 2022

The ongoing rise in the number of cancer cases raises concerns regarding the efficacy of the various treatment methods that are currently available. Consequently, patients are looking for alternatives to traditional cancer treatments such as surgery,...

  • Article
  • Open Access
12 Citations
3,333 Views
17 Pages

A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells

  • Hui Hua Chang,
  • Yao-Yuan Chang,
  • Bing-Chen Tsai,
  • Li-Jyun Chen,
  • An-Chi Chang,
  • Jian-Ying Chuang,
  • Po-Wu Gean and
  • Yuan-Shuo Hsueh

19 September 2022

Glioblastoma multiforme (GBM) is a grade IV, highly malignant brain tumor. Because of the heterogeneity of GBM, a multitarget drug is a rational strategy for GBM treatment. Histone deacetylase inhibitors (HDACis) regulate the expression of numerous g...

  • Review
  • Open Access
25 Citations
5,041 Views
20 Pages

MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development

  • Wen (Jess) Li,
  • Xiaozhuo Liu,
  • Emily M. Dougherty and
  • Dean G. Tang

19 September 2022

Prostate cancer (PCa) is a highly heterogeneous disease and typically presents with multiple distinct cancer foci. Heterogeneity in androgen receptor (AR) expression levels in PCa has been observed for decades, from untreated tumors to castration-res...

  • Review
  • Open Access
8 Citations
4,381 Views
25 Pages

Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis

  • Angeliki-Ioanna Giannopoulou,
  • Charalampos Xanthopoulos,
  • Christina Piperi and
  • Efterpi Kostareli

19 September 2022

Gliomas encompass a vast category of CNS tumors affecting both adults and children. Treatment and diagnosis are often impeded due to intratumor heterogeneity and the aggressive nature of the more malignant forms. It is therefore essential to elucidat...

  • Article
  • Open Access
7 Citations
3,160 Views
24 Pages

19 September 2022

Relapsed, recurrent, chemotherapy-resistant high-grade serous ovarian carcinoma is the deadliest stage of this disease. Expression of microtubule-associated protein tau (tau) has been linked to resistance to paclitaxel treatment. Here, I used models...

  • Article
  • Open Access
6 Citations
3,973 Views
12 Pages

19 September 2022

Deep convolutional neural network (CNN) helped enhance image quality of cone-beam computed tomography (CBCT) by generating synthetic CT. Most of the previous works, however, trained network by intensity-based loss functions, possibly undermining to p...

  • Article
  • Open Access
7 Citations
3,265 Views
19 Pages

Comparison of Selected Non-Coding RNAs and Gene Expression Profiles between Common Osteosarcoma Cell Lines

  • Mateusz Sikora,
  • Katarzyna Krajewska,
  • Klaudia Marcinkowska,
  • Anna Raciborska,
  • Rafał Jakub Wiglusz and
  • Agnieszka Śmieszek

19 September 2022

Osteosarcoma (OS) is a bone tumour affecting adolescents and elderly people. Unfortunately, basic treatment methods are still underdeveloped, which has a high impact on the poor survivability of the patients. Studies designed to understand the underl...

  • Article
  • Open Access
7 Citations
3,351 Views
21 Pages

19 September 2022

Eribulin, a natural product-based microtubule targeting agent with cytotoxic and noncytotoxic mechanisms, is FDA approved for certain patients with advanced breast cancer and liposarcoma. To investigate the feasibility of developing drug-specific pre...

  • Commentary
  • Open Access
21 Citations
3,612 Views
10 Pages

The Evolving Interplay of SBRT and the Immune System, along with Future Directions in the Field

  • Mihailo Miljanic,
  • Steven Montalvo,
  • Maureen Aliru,
  • Tidie Song,
  • Maria Leon-Camarena,
  • Kevin Innella,
  • Dragan Vujovic,
  • Ritsuko Komaki and
  • Puneeth Iyengar

19 September 2022

In this commentary, we describe the potential of highly ablative doses utilizing Stereotactic Body Radiation Therapy (SBRT) in single or few fractions to enhance immune-responsiveness, how timing of this approach in combination with immune-checkpoint...

  • Article
  • Open Access
8 Citations
4,816 Views
12 Pages

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

  • Raquel Ciérvide,
  • Ángel Montero,
  • Eduardo García-Rico,
  • Mariola García-Aranda,
  • Mercedes Herrero,
  • Jessica Skaarup,
  • Leticia Benassi,
  • Maria José Barrera,
  • Estela Vega and
  • Carmen Rubio
  • + 22 authors

19 September 2022

Primary systemic treatment (PST) downsizes the tumor and improves pathological response. The aim of this study is to analyze the feasibility and tolerance of primary concurrent radio–chemotherapy (PCRT) in breast cancer patients. Patients with...

  • Review
  • Open Access
14 Citations
3,295 Views
16 Pages

19 September 2022

Recent advances in research have led to earlier diagnosis and targeted therapies against breast cancer, which has resulted in reduced breast cancer-related mortality. However, the majority of breast cancer-related deaths are due to metastasis of canc...

  • Review
  • Open Access
28 Citations
3,798 Views
12 Pages

Surgical Site Infection after Bone Tumor Surgery: Risk Factors and New Preventive Techniques

  • Shinji Miwa,
  • Norio Yamamoto,
  • Katsuhiro Hayashi,
  • Akihiko Takeuchi,
  • Kentaro Igarashi and
  • Hiroyuki Tsuchiya

19 September 2022

The management of malignant bone tumors requires multidisciplinary interventions including chemotherapy, radiation therapy, and surgical tumor resection and reconstruction. Surgical site infection (SSI) is a serious complication in the treatment of m...

  • Correction
  • Open Access
2 Citations
2,192 Views
2 Pages

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109

  • Dongyu Zhang,
  • Neil J. Shah,
  • Michael Cook,
  • Matthew Blackburn,
  • Michael T. Serzan,
  • Shailesh Advani,
  • Arnold L. Potosky,
  • Subha Madhavan,
  • Anas Belouali and
  • Dejana Braithwaite
  • + 1 author

19 September 2022

Subha Madhavan (S.M.) and Anas Belouali (A.B.) were not included as authors in the published article [...]

  • Review
  • Open Access
10 Citations
5,171 Views
16 Pages

Emerging Roles of Lipophagy in Cancer Metastasis

  • Haimeng Yin,
  • Ying Shan,
  • Tian Xia,
  • Yan Ji,
  • Ling Yuan,
  • Yiwen You and
  • Bo You

19 September 2022

Obesity is a prominent risk factor for certain types of tumor progression. Adipocytes within tumor stroma contribute to reshaping tumor microenvironment (TME) and the metabolism and metastasis of tumors through the production of cytokines and adipoki...

  • Article
  • Open Access
14 Citations
3,929 Views
25 Pages

Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma

  • Rok Razpotnik,
  • Robert Vidmar,
  • Marko Fonović,
  • Damjana Rozman and
  • Tadeja Režen

19 September 2022

Circular RNAs (circRNAs) have been shown to play an important role in the pathogenesis of hepatocellular carcinoma (HCC). By implementing available transcriptomic analyses of HCC patients, we identified an upregulated circRNA hsa_circ_0062682. Stable...

  • Review
  • Open Access
11 Citations
5,027 Views
16 Pages

Immunotherapy and Hepatocellular Cancer: Where Are We Now?

  • Marine Valery,
  • Baptiste Cervantes,
  • Ramy Samaha,
  • Maximiliano Gelli,
  • Cristina Smolenschi,
  • Alina Fuerea,
  • Lambros Tselikas,
  • Caroline Klotz-Prieux,
  • Antoine Hollebecque and
  • Michel Ducreux
  • + 1 author

19 September 2022

Immunotherapy has demonstrated its effectiveness in many cancers. In hepatocellular carcinoma (HCC), promising results shown in the first phase II studies evaluating anti-PD-1 or anti-PD-L1 monotherapies resulted in their approval in the United State...

  • Article
  • Open Access
6 Citations
4,391 Views
19 Pages

18 September 2022

Background: Acyl-CoA thioesterase 7 (ACOT7) is of great significance in regulating cell cycle, cell proliferation, and glucose metabolism. The function of ACOT7 in pan-cancer and its capacity as a prognostic indicator in lung adenocarcinoma (LUAD) re...

  • Article
  • Open Access
7 Citations
2,789 Views
12 Pages

Body Composition as a Predictor of the Survival in Anal Cancer

  • Ahmed Allam Mohamed,
  • Kathrin Risse,
  • Jennifer Stock,
  • Alexander Heinzel,
  • Felix M. Mottaghy,
  • Philipp Bruners and
  • Michael J. Eble

18 September 2022

Background and aim: Sarcopenia and body composition parameters such as visceral and subcutaneous adipose tissue and visceral-to-subcutaneous adipose tissue ratio have been shown to be relevant biomarkers for prognosis in patients with different types...

  • Article
  • Open Access
8 Citations
2,863 Views
16 Pages

Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy

  • Ting Wu,
  • Dan Yan,
  • Wenjun Hou,
  • Hui Jiang,
  • Min Wu,
  • Yanling Wang,
  • Gang Chen,
  • Chunming Tang,
  • Yijun Wang and
  • Huae Xu

18 September 2022

As one of the most common cancers worldwide, non-small-cell lung cancer (NSCLC) treatment always fails owing to the tumor microenvironment and resistance. UA, a traditional Chinese medicine, was reported to have antitumor potential in tumor models in...

  • Review
  • Open Access
13 Citations
8,518 Views
12 Pages

18 September 2022

TP53-mutated acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are among the myeloid malignancies with the poorest prognosis. In this review, we analyze the prognosis of these two diseases, focussing particularly on the extent of the m...

  • Review
  • Open Access
22 Citations
3,703 Views
20 Pages

17 September 2022

Hypoxia is a common feature associated with many types of cancer. The activity of the hypoxia-inducible factors (HIFs), the critical element of response and adaptation to hypoxia, enhances cancer hallmarks such as suppression of the immune response,...

  • Article
  • Open Access
15 Citations
5,130 Views
15 Pages

Surgical and Functional Outcome after Resection of 64 Petroclival Meningiomas

  • Arthur Wagner,
  • Marie Alraun,
  • Victoria Kahlig,
  • Anne-Sophie Dorier,
  • Amir Kaywan Aftahy,
  • Denise Bernhardt,
  • Stephanie E. Combs,
  • Jens Gempt,
  • Ehab Shiban and
  • Chiara Negwer
  • + 1 author

17 September 2022

Objective: The management of petroclival meningiomas (PCMs) remains notoriously difficult due to their close association with neurovascular structures and their complex anatomy, hence the surgical paradigm change from radical to functional resection...

  • Article
  • Open Access
7 Citations
3,918 Views
16 Pages

Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features

  • Shady I. Soliman,
  • Farhoud Faraji,
  • John Pang,
  • Loren K. Mell,
  • Joseph A. Califano and
  • Ryan K. Orosco

17 September 2022

Purpose: HPV-positive oropharyngeal carcinoma (HPV-OPC) is increasingly treated with primary surgery. The National Comprehensive Cancer Network (NCCN) recommends adjuvant therapy for surgically treated HPV-OPC displaying adverse pathological features...

  • Review
  • Open Access
3 Citations
5,840 Views
19 Pages

17 September 2022

Endometrial cancer is the most common gynecological tract malignancy in developed countries, and its incidence has been increasing globally with rising obesity rates and longer life expectancy. In endometrial cancer, extrauterine disease, in particul...

  • Article
  • Open Access
2 Citations
2,041 Views
9 Pages

Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis

  • Ching-Feng Lien,
  • Chien-Chung Wang,
  • Chuan-Chien Yang,
  • Chih-Chun Wang,
  • Tzer-Zen Hwang,
  • Yu-Chen Shih,
  • Shyh-An Yeh and
  • Meng-Che Hsieh

17 September 2022

Concurrent chemoradiotherapy (CCRT) with a cisplatin-based regimen is the standard treatment for patients with nasopharyngeal carcinoma (NPC). Our study was a propensity-score-matching analysis and it aimed to investigate the oncologic outcomes of pl...

  • Article
  • Open Access
3 Citations
3,197 Views
13 Pages

Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism

  • Aiham Qdaisat,
  • Adriana H. Wechsler,
  • Maria T. Cruz Carreras,
  • Jazmin R. Menendez,
  • Demis Lipe,
  • Emily A. Highsmith,
  • Mona Kamal,
  • Aisha Al-Breiki,
  • Cristhiam M. Rojas Hernandez and
  • Sai-Ching J. Yeung
  • + 1 author

17 September 2022

Incidental venous thromboembolism (VTE) is common in cancer patients and identifying factors associated with these events can improve the management plan. We studied the characteristics of concomitant deep vein thrombosis (C-DVT) in cancer patients p...

  • Article
  • Open Access
4 Citations
2,800 Views
11 Pages

Pure Solid Pattern of Non-Small Cell Lung Cancer and Clustered Circulating Tumor Cells

  • Noriyoshi Sawabata,
  • Takeshi Kawaguchi,
  • Takashi Watanabe,
  • Daiki Yohikawa,
  • Noriko Ouji-Sageshima and
  • Toshihiro Ito

17 September 2022

There are two solid patterns of non-small cell lung cancer (NSCLC) on computed tomography (CT): pure or mixed with ground-glass opacities (GGOs). They predict the degree of invasiveness, which may suggest the presence of clustered circulating tumor c...

  • Review
  • Open Access
18 Citations
5,988 Views
16 Pages

17 September 2022

Background: Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome that affects about 1 in 3000 newborns, is caused by mutations in the NF1 gene and subsequent inactivation of its encoded neurofibromin. Neurofibromin is a tumor suppr...

  • Article
  • Open Access
10 Citations
3,011 Views
18 Pages

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

  • Yanyan Zheng,
  • Zheng Lu,
  • Jiage Ding,
  • Nan Jiang,
  • Jiawei Wang,
  • Jie Yang,
  • Jingyuan Song,
  • Hongliang Chen,
  • Lin Fang and
  • Dafei Chai
  • + 4 authors

17 September 2022

Hepatocellular carcinoma (HCC) is one of the cancers with the highest morbidity and mortality in the world. However, clinical progress in the treatment of HCC has not shown a satisfactory therapeutic effect. Here, we have developed a novel strategy t...

  • Article
  • Open Access
8 Citations
2,942 Views
14 Pages

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study

  • Diane Evrard,
  • Clément Dumont,
  • Michel Gatineau,
  • Jean-Pierre Delord,
  • Jérôme Fayette,
  • Chantal Dreyer,
  • Annemilaï Tijeras-Raballand,
  • Armand de Gramont,
  • Jean-François Delattre and
  • Sandrine Faivre
  • + 7 authors

17 September 2022

Mammalian target of rapamycin (mTOR) regulates cellular functions by integrating intracellular signals and signals from the tumor microenvironment (TME). The PI3K-AKT-mTOR pathway is activated in 70% of head and neck squamous cell carcinoma (HNSCC) a...

  • Article
  • Open Access
11 Citations
3,223 Views
15 Pages

Role of Fe, Transferrin and Transferrin Receptor in Anti-Tumor Effect of Vitamin C

  • Jia Qiu,
  • Renbo Wu,
  • Yali Long,
  • Lei Peng,
  • Tianhong Yang,
  • Bing Zhang,
  • Xinchong Shi,
  • Jianbo Liu and
  • Xiangsong Zhang

17 September 2022

High-dose vitamin C (VC) exhibits anti-tumor effects, and the cytotoxicity of VC is correlated with oxidative stress. However, iron, as a redox metal, plays an important effect in redox cycling and free radical formation in cells. This study addresse...

  • Article
  • Open Access
13 Citations
3,849 Views
12 Pages

Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen

  • Jiujun Zhu,
  • Dechuang Jiao,
  • Chengzheng Wang,
  • Zhenduo Lu,
  • Xiuchun Chen,
  • Lianfang Li,
  • Xianfu Sun,
  • Li Qin,
  • Xuhui Guo and
  • Zhenzhen Liu
  • + 4 authors

17 September 2022

(1) Background: The objective of our study was to provide evidence for choosing the optimal neoadjuvant therapy strategies for patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Three neoadjuvant targeted ther...

  • Article
  • Open Access
5 Citations
3,479 Views
14 Pages

The Effect of Atm Loss on Radiosensitivity of a Primary Mouse Model of Pten-Deleted Brainstem Glioma

  • Connor E. Stewart,
  • María E. Guerra-García,
  • Lixia Luo,
  • Nerissa T. Williams,
  • Yan Ma,
  • Joshua A. Regal,
  • Debosir Ghosh,
  • Patrick Sansone,
  • Mark Oldham and
  • Zachary J. Reitman
  • + 3 authors

17 September 2022

Diffuse midline gliomas arise in the brainstem and other midline brain structures and cause a large proportion of childhood brain tumor deaths. Radiation therapy is the most effective treatment option, but these tumors ultimately progress. Inhibition...

  • Review
  • Open Access
10 Citations
6,139 Views
28 Pages

Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood

  • Isobelle Wall,
  • Victoire Boulat,
  • Aekta Shah,
  • Kim R. M. Blenman,
  • Yin Wu,
  • Elena Alberts,
  • Dinis Pedro Calado,
  • Roberto Salgado and
  • Anita Grigoriadis

17 September 2022

During the anti-tumour response to breast cancer, the primary tumour, the peripheral blood, and the lymph nodes each play unique roles. Immunological features at each site reveal evidence of continuous immune cross-talk between them before, during an...

  • Article
  • Open Access
12 Citations
2,752 Views
18 Pages

Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection

  • Simona Bernardi,
  • Mirko Farina,
  • Katia Bosio,
  • Anna Di Lucanardo,
  • Alessandro Leoni,
  • Federica Re,
  • Nicola Polverelli,
  • Alessandro Turra,
  • Enrico Morello and
  • Domenico Russo
  • + 4 authors

16 September 2022

Exosomes are extracellular vesicles playing a pivotal role in the intercellular communication. They shuttle different cargoes, including nucleic acids from their cell of origin. For this reason, they have been studied as carriers of tumor markers in...

  • Article
  • Open Access
6 Citations
3,301 Views
20 Pages

16 September 2022

Oxidative phosphorylation (OXPHOS) is an emerging target in cancer therapy. However, the prognostic signature of OXPHOS in colorectal adenocarcinoma (COAD) remains non-existent. We comprehensively investigated the expression pattern of OXPHOS-related...

  • Review
  • Open Access
33 Citations
5,704 Views
24 Pages

Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis

  • Ranakul Islam,
  • Lei Zhao,
  • Yifang Wang,
  • Grace Lu-Yao and
  • Ling-Zhi Liu

16 September 2022

Arsenic is a crucial environmental metalloid whose high toxicity levels negatively impact human health. It poses significant health concerns to millions of people in developed and developing countries such as the USA, Canada, Bangladesh, India, China...

  • Article
  • Open Access
6 Citations
2,508 Views
20 Pages

Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies

  • Sanne J. M. Hoefnagel,
  • Willem J. Koemans,
  • Hina N. Khan,
  • Jan Koster,
  • Sybren L. Meijer,
  • Jolanda M. van Dieren,
  • Liudmila L. Kodach,
  • Johanna W. van Sandick,
  • Silvia Calpe and
  • Kausilia K. Krishnadath
  • + 7 authors

16 September 2022

Esophageal adenocarcinoma (EAC) is a highly aggressive cancer and its response to chemo- and radiotherapy is unpredictable. EACs are highly heterogeneous at the molecular level. The aim of this study was to perform gene expression analysis of EACs to...

  • Article
  • Open Access
7 Citations
2,647 Views
13 Pages

Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma

  • Erin L. Schenk,
  • Jennifer M. Boland,
  • Sarah G. Withers,
  • Peggy A. Bulur and
  • Allan B. Dietz

16 September 2022

Patients with early-stage lung adenocarcinoma have a high risk of recurrent or metastatic disease despite undergoing curative intent therapy. We hypothesized that increased CD14+ cells within the tumor microenvironment (TME) could stratify patient ou...

  • Review
  • Open Access
51 Citations
5,492 Views
20 Pages

Current Approaches to the Management of Patients with Endometrial Cancer

  • Emmanouil Kalampokas,
  • Georgios Giannis,
  • Theodoros Kalampokas,
  • Angeliki-Astero Papathanasiou,
  • Dimitra Mitsopoulou,
  • Evangelia Tsironi,
  • Olga Triantafyllidou,
  • Mahalakshmi Gurumurthy,
  • David E. Parkin and
  • Nikolaos F. Vlahos
  • + 1 author

16 September 2022

The incidence of endometrial cancer (EC) is rising and healthcare professionals need to be informed about the latest data on the constant developments in the field of its management. With particular interest in the classification and management of EC...

  • Review
  • Open Access
39 Citations
8,709 Views
15 Pages

Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?

  • Michael J. Duffy,
  • Minhong Tang,
  • Subhasree Rajaram,
  • Shane O’Grady and
  • John Crown

16 September 2022

Mutant p53 is one of the most attractive targets for new anti-cancer drugs. Although traditionally regarded as difficult to drug, several new strategies have recently become available for targeting the mutant protein. One of the most promising of the...

  • Article
  • Open Access
16 Citations
4,220 Views
12 Pages

Clinical Utility of Rapid On-Site Evaluation of Touch Imprint Cytology during Cryobiopsy for Peripheral Pulmonary Lesions

  • Yutaka Muto,
  • Keigo Uchimura,
  • Tatsuya Imabayashi,
  • Yuji Matsumoto,
  • Hideaki Furuse and
  • Takaaki Tsuchida

16 September 2022

Cryobiopsy enables us to obtain larger specimens than conventional forceps biopsy despite the caution regarding complications. This study aimed to evaluate the clinical utility of rapid on-site evaluation of touch imprint cytology (ROSE-TIC) during c...

  • Article
  • Open Access
14 Citations
5,231 Views
20 Pages

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells

  • Kajal Rajput,
  • Mohammad Nafees Ansari,
  • Somesh K. Jha,
  • Trishna Pani,
  • Nihal Medatwal,
  • Somdeb Chattopadhyay,
  • Avinash Bajaj and
  • Ujjaini Dasgupta

16 September 2022

Sphingolipids are key signaling biomolecules that play a distinct role in cell proliferation, migration, invasion, drug resistance, metastasis, and apoptosis. Triple-negative (ER−PR−HER2−) and triple-positive (ER+PR+HER2+) breast ca...

  • Article
  • Open Access
10 Citations
2,856 Views
10 Pages

CTRP1 Knockout Attenuates Tumor Progression in A549 and HCT116 Cancer Cells

  • Rackhyun Park,
  • Yea-In Park,
  • Yeonjeong Park,
  • Siyun Lee,
  • Jaeyeon So and
  • Junsoo Park

16 September 2022

C1q and TNF-related 1 (C1QTNF1/CTRP1) is an adiponectin-associated protein belonging to the C1q/TNF-related protein family. Recent studies have shown that the C1q and TNF-related protein (CTRP) family is involved in cancer progression; however, the s...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694